Comparison of a bacteriophage-delivered DNA vaccine and a commercially available recombinant protein vaccine against hepatitis B

By Clark Jason R.   Bartley Kathryn   Jepson Catherine D.   Craik Vicki   March John B.  

FEMS Immunology & Medical Microbiology, Vol. 61, Iss. 2, 2011-03 ,pp. : 197-204

Blackwell Publishing

Access to resources Recommend Favorite

Identification and Characterization of a Structural Protein of Hepatitis B Virus: A Polymerase and Surface Fusion Protein Encoded by a Spliced RNA

By Huang H.-L.   Jeng K.-S.   Hu C.-P.   Tsai C.-H.   Lo S.J.   Chang C.  

Virology, Vol. 275, Iss. 2, 2000-09 ,pp. : 398-410

Elsevier

Access to resources Recommend Favorite

Reduced Antigenicity of the Hepatitis B Virus HBsAg Protein Arising as a Consequence of Sequence Changes in the Overlapping Polymerase Gene That Are Selected by Lamivudine Therapy

By Torresi J.   Earnest-Silveira L.   Deliyannis G.   Edgtton K.   Zhuang H.   Locarnini S.A.   Fyfe J.   Sozzi T.   Jackson D.C.  

Virology, Vol. 293, Iss. 2, 2002-02 ,pp. : 305-313

Elsevier

Access to resources Recommend Favorite

Mutation in a 17D-204 Vaccine Substrain-Specific Envelope Protein Epitope Alters the Pathogenesis of Yellow Fever Virus in Mice

By Ryman K.D.   Ledger T.N.   Campbell G.A.   Watowich S.J.   Barrett A.D.T.  

Virology, Vol. 244, Iss. 1, 1998-04 ,pp. : 59-65

Elsevier

Access to resources Recommend Favorite

Hepatitis B virus genotyping based on cluster analysis of the region involved in lamivudine resistance

By Rodriguez-Novoa S.   Gomez-Tato A.   Aguilera-Guirao A.   Castroagudin J.   Gonzalez-Quintela A.   Garcia-Riestra C.   Regueiro B.J.  

Journal of Virological Methods, Vol. 115, Iss. 1, 2004-01 ,pp. : 9-17

Elsevier

Access to resources Recommend Favorite